| SC 13D/A | 2017-06-27 | CELGENE CORP /DE/ | Alliqua BioMedical, Inc. | 9,025,194 | 18.8% | EDGAR |
| SC 13D/A | 2017-04-13 | CELGENE CORP /DE/ | Alliqua BioMedical, Inc. | 8,321,471 | 19.9% | EDGAR |
| SC 13D/A | 2017-03-29 | CELGENE CORP /DE/ | Alliqua BioMedical, Inc. | 8,025,194 | 19.9% | EDGAR |
| SC 13D/A | 2017-03-16 | CELGENE CORP /DE/ | Alliqua BioMedical, Inc. | 8,025,194 | 19.9% | EDGAR |
| SC 13D/A | 2017-03-01 | CELGENE CORP /DE/ | Alliqua BioMedical, Inc. | 8,025,194 | 22.2% | EDGAR |
| SC 13G/A | 2017-02-10 | VANGUARD GROUP INC | CELGENE CORP /DE/ | 49,849,549 | 6.4% | EDGAR |
| SC 13G/A | 2017-01-23 | BlackRock Inc. | CELGENE CORP /DE/ | 51,841,792 | 6.7% | EDGAR |
| SC 13D | 2016-10-31 | CELGENE CORP /DE/ | CRISPR Therapeutics AG | 4,834,980 | 12.3% | EDGAR |
| SC 13G | 2016-08-24 | CELGENE CORP /DE/ | OncoMed Pharmaceuticals Inc | 2,970,588 | 8.1% | EDGAR |
| SC 13G/A | 2016-02-10 | BlackRock Inc. | CELGENE CORP /DE/ | 53,056,161 | 6.8% | EDGAR |
| SC 13G/A | 2016-02-10 | VANGUARD GROUP INC | CELGENE CORP /DE/ | 46,398,324 | 5.9% | EDGAR |
| SC 13D/A | 2016-01-11 | CELGENE CORP /DE/ | ACCELERON PHARMA INC | 5,411,866 | 14.6% | EDGAR |
| SC 13D/A | 2015-05-04 | CELGENE CORP /DE/ | Alliqua BioMedical, Inc. | 4,025,194 | 15.9% | EDGAR |
| SC 13G/A | 2015-02-13 | CELGENE CORP /DE/ | TENGION INC | - | - | EDGAR |
| SC 13G | 2015-02-13 | CELGENE CORP /DE/ | Atara Biotherapeutics, Inc. | 1,256,235 | - | EDGAR |
| SC 13G/A | 2015-02-11 | CELGENE CORP /DE/ | OncoMed Pharmaceuticals Inc | 1,470,588 | 4.9% | EDGAR |
| SC 13G | 2015-02-10 | VANGUARD GROUP INC | CELGENE CORP /DE/ | 42,954,327 | 5.4% | EDGAR |
| SC 13G/A | 2015-02-09 | BlackRock Inc. | CELGENE CORP /DE/ | 50,495,857 | 6.3% | EDGAR |
| SC 13D/A | 2014-05-06 | CELGENE CORP /DE/ | ACCELERON PHARMA INC | 4,611,866 | 14.6% | EDGAR |
| SC 13D/A | 2014-04-15 | CELGENE CORP /DE/ | Alliqua, Inc. | 3,222,997 | 19.7% | EDGAR |